My Personal CFO LLC’s Edwards Lifesciences EW Stock Holding History

My Personal CFO LLC’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-28	Closed	-$2.09K	–	318
2022 Q4	$2.09K	Buy	+28	New	+$2.16K	﹤0.01%	507

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

My Personal CFO LLC's EW Position: Q1 2023 in Review

My Personal CFO LLC sold out of Edwards Lifesciences (EW) in Q1 2023, closing a stake of 28 shares — an estimated $2.09K sold.

My Personal CFO LLC first reported a position in EW in Q4 2022 and held it in 1 quarter. The position peaked at $2.09K in Q4 2022. 1,245 funds tracked by Wall St. Rank hold EW as of Q1 2023.

My Personal CFO LLC reported no remaining Edwards Lifesciences position as of Q1 2023 after selling out during the quarter.
My Personal CFO LLC sold 28 Edwards Lifesciences shares in Q1 2023, an estimated $2.09K.
My Personal CFO LLC first reported a position in Edwards Lifesciences in Q4 2022 and held it in 1 quarter.
My Personal CFO LLC's Edwards Lifesciences position peaked at $2.09K in Q4 2022.
1,245 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2023.

Based on My Personal CFO LLC's 13F filing for Q1 2023, filed 21 Apr 2023.